Zymeworks Inc. has grown revenue −56% a year over three years and 22% a year over five. Revenue growth, 3-year annual rate: −56% (Biotechnology median +17%). Revenue growth, 5-year rate: +22%, growth has slowed since the five-year average. Years of annual history on file: 6, FY2020 to FY2025, as filed.

ZYMEZymeworks Inc.

Healthcare

$25.80+59% 1Y

$25.80

$16.1652 weeks$31.05

Is it growing?

Watch

Growth is fading: revenue shrinking (−70% year on year) and operating margin narrowing (−1082.5 points).

2 to watch, 1 without data

Revenue trend−70% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Margin direction−1082.5 points operating

Trailing-twelve-month operating margin, -1177.8% now against -95.3% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is ZYME growing?

Zymeworks Inc. has grown revenue −56% a year over three years and 22% a year over five.

−56%

Revenue growth, 3-year annual rate · Biotechnology median +17% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +22%
Revenue growth, 5-year rate · −56% over three · growth has slowed since the five-year average
Years of annual history on file: 6
Years of annual history on file · FY2020 to FY2025, as filed

Details›